港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

高瓴概念

484.499

+4.5070.94%

漲家數：21

跌家數：25

平家數：9

市盈率：- -

高：487.049

開：479.969

低：478.246

收：479.992

資料載入中...

京東健康盤中異動快速上漲3.07%

中升控股盤中異動大幅拉昇5.15%報12.260港元

明源雲盤中異動早盤股價大漲5.02%

中國鐵塔應急無人直升機空中基站招標宣佈終止

中国通信网

信義能源宣佈7月30日派發末期股息每股2.7港仙

中國信達資產管理被罰90萬元：未報送境外附屬機構人員任職申請等

信義能源將於7月30日派發末期股息每股2.7港仙

雲頂新耀(01952)：耐賦康®獲國家藥監局完全批准用於治療Ig A腎病

【券商聚焦】華泰證券：電力現貨市場催生五大投資機會

【晨觀方正】君實生物 / 易普力 / 軍工24年報/25一季報分析 20250507

方正证券研究

雲頂新耀“布地奈德腸溶膠囊”在國內獲完全批准

医药魔方Info

【灣區早參】香港金管局調查：75%中小企指上季銀行貸款批核取態無分別或較容易

Bitwise已向美國SEC提交現貨NEAR ETF的上市申請

萬泰生物艾滋自檢試劑通過世衞組織PQ認證；歸創通橋5月9日起摘“B”丨醫藥早參

每日经济新闻

【雲頂新耀(01952.HK)：耐賦康®獲得中國國家藥品監督管理局完全批准用於治療具有疾病進展風險的原發性IgA腎病成人患者】雲頂新耀(01952.HK)發佈公告，耐賦康®(NEFECON®)已獲中國國家藥品監督管理局的完全批准，取消了對蛋白尿水平的限制，用於治療具有疾病進展風險的原發性IgA腎病成人患者。此次完全批准意味着耐賦康®成為中國首個且唯一獲得中國藥監局完全批准的IgA腎病對因治療藥物。

雲頂新耀(01952)：耐賦康獲得中國國家藥品監督管理局完全批准用於治療具有疾病進展風險的原發性IgA腎病成人患者

智通财经网

Bitwise 提交現貨 NEAR ETF 的 S-1 申請

建業新生活“迎舊人” 王俊時隔三年重回CEO

歸創通橋成為港股首家成功“摘B”的18A高值耗材醫療器械公司

灰度：Diana Zhang 將擔任首席運營官

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1583/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":484.49942,"timestamp":1746676799209,"preClose":479.99228,"halted":0,"volume":190108332,"delay":0,"changeRate":0.00939,"floatShares":0,"shares":0,"eps":0,"marketStatus":"午間休市","change":4.507141,"latestTime":"05-08 12:00:43","open":479.96893,"high":487.04926,"low":478.24628,"amount":5721088485,"amplitude":0.01834,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1746680400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1746667800000,1746676800000],[1746680400000,1746691200000]],"pbRate":2.274471,"peRate":22.060651,"turnoverRate":0.00138,"increases":21,"decrements":25,"flats":8,"marketCap":2724127567872,"floatMarketCap":2147195650560},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":487.04926,"amplitude":0.01834,"preClose":479.99228,"low":478.24628,"pbRate":"2.274471","latestPrice":484.49942,"volume":190108332,"delay":0,"open":479.96893,"prevYearClose":446.93042,"prevWeekClose":480.455,"prevMonthClose":473.358,"prevQuarterClose":505.776,"fiveDayClose":471.383,"twentyDayClose":510.938,"sixtyDayClose":456.991,"secType":"PLATE","market":"HK","turnoverRate":0.00138,"peRate":22.060651,"marketCap":2724127567872,"floatMarketCap":2147195650560,"timestamp":1746676799209,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":21,"down":25,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533611600","title":"京東健康盤中異動 快速上漲3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533611600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533611600?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 09:31","pubTimestamp":1746581508,"startTime":"0","endTime":"0","summary":"2025年05月07日早盘09时31分，京东健康股票出现异动，股价大幅上涨3.07%。京东健康股票所在的药品分销行业中，整体涨幅为0.10%。报告期内，公司实现营业总收入599.27亿元，同比增长11.55%；归母净利润41.62亿元，同比增长94.31%；经营活动产生的现金流量净额为43.32亿元，同比下降5.92%；据报告显示，京东健康基本每股收益为1.32元，加权平均净资产收益率为7.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050709314997514eec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050709314997514eec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1571","BK1142","06618","BK1591","BK1247","BK1515","LU0456827905.SGD","LU0051755006.USD","BK1589","BK1583","86618","BK1615"],"gpt_icon":0},{"id":"2533361159","title":"中升控股盤中異動 大幅拉昇5.15%報12.260港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533361159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533361159?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 09:31","pubTimestamp":1746581504,"startTime":"0","endTime":"0","summary":"2025年05月07日早盘09时31分，中升控股股票出现异动，股价大幅上涨5.15%。截至发稿，该股报12.260港元/股，成交量106.9万股，换手率0.05%，振幅4.80%。中升控股股票所在的汽车零售商行业中，整体涨幅为0.12%。中升控股公司简介：汽车的销售及服务消息层面，截至09时31分，《中升控股：2024年净利润同比下降35.99% 拟每股派息0.678港元》资讯为影响中升控股的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507093144aa2c8528&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507093144aa2c8528&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0173614495.USD","BK1239","LU0287142896.SGD","BK1520","00881","BK1589","LU1102505762.USD","BK1583"],"gpt_icon":0},{"id":"2533611597","title":"明源雲盤中異動 早盤股價大漲5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533611597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533611597?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 09:30","pubTimestamp":1746581408,"startTime":"0","endTime":"0","summary":"2025年05月07日早盘09时30分，明源云股票出现异动，股价大幅上涨5.02%。截至发稿，该股报3.140港元/股，成交量30.2万股，换手率0.02%，振幅2.01%。明源云股票所在的应用软件行业中，整体涨幅为0.41%。其相关个股中，捷利交易宝、九方智投控股、明源云涨幅较大，振幅较大的相关个股有明源云、阜博集团、九方智投控股，振幅分别为2.01%、1.23%、1.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050709300894ee99df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050709300894ee99df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1518","00909","BK1117","BK1583","BK1607","BK1589","BK1618"],"gpt_icon":0},{"id":"2533643962","title":"中國鐵塔應急無人直升機空中基站招標宣佈終止","url":"https://stock-news.laohu8.com/highlight/detail?id=2533643962","media":"中国通信网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533643962?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 09:27","pubTimestamp":1746581275,"startTime":"0","endTime":"0","summary":"昨日， 中国铁塔 发布公告，宣布2025年应急无人直升机空中基站采购项目招标终止。招标终止原因为：本项目采购需求发生变更，经招标人确认，终止本次招标。此前公告显示，本项目原是为了提升应急 通信 保障能力，计划采购无人直升机平台、全网通基站、机载卫星终端、地面卫星便携站以及光电吊舱各1套。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507095545a6d5b4fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507095545a6d5b4fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BHRH8D16.HKD","00788","BK1133","BK1190","BK1181","IE00BHRH8C09.USD","BK1521","BK1583","BK1589","BK1529","02943","IE00BG0RBZ43.SGD","LU0823413660.USD","LU0823413587.USD","BK1506"],"gpt_icon":0},{"id":"2533616326","title":"信義能源宣佈7月30日派發末期股息每股2.7港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2533616326","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533616326?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 09:25","pubTimestamp":1746581102,"startTime":"0","endTime":"0","summary":"信义能源（03868）公布将于2025年7月30日派发末期股息，每股2.7港仙。此举旨在回馈股东支持，体现公司稳健的财务状况及可持续发展能力。投资者可留意具体派息日期以及时获取收益。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050709274197514cef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050709274197514cef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1154","BK1583","BK1554","BK1594","03868"],"gpt_icon":0},{"id":"2533611500","title":"中國信達資產管理被罰90萬元：未報送境外附屬機構人員任職申請等","url":"https://stock-news.laohu8.com/highlight/detail?id=2533611500","media":"投资快报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533611500?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 09:14","pubTimestamp":1746580443,"startTime":"0","endTime":"0","summary":"4月30日消息，金融监管总局行政处罚信息公开表的一则处罚信息，在金融领域引发广泛关注。中国信达资产管理股份有限公司因未按规定向监管部门报送境外全资附属金融机构聘任的董事和高级管理人员的任职申请和报告，被处以90万元罚款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507093022a6d5acd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507093022a6d5acd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1156","BK1258","BK1229","09983","BK1583","01359","BK1542"],"gpt_icon":0},{"id":"2533616525","title":"信義能源將於7月30日派發末期股息每股2.7港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2533616525","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533616525?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 09:06","pubTimestamp":1746579960,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　信义能源（03868）公布，将于2025年7月30日派发末期股息每股2.7港仙。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-07/doc-inevswwc3796170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1154","BK1583","BK1554","BK1594","03868"],"gpt_icon":0},{"id":"2533615865","title":"雲頂新耀(01952)：耐賦康®獲國家藥監局完全批准用於治療Ig A腎病","url":"https://stock-news.laohu8.com/highlight/detail?id=2533615865","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533615865?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 09:04","pubTimestamp":1746579892,"startTime":"0","endTime":"0","summary":"此次完全批准意味着耐赋康成为中国首个且唯一获得中国药监局完全批准的Ig A肾病对因治疗药物。此次获批是基于Nef Ig Ard III期临床研究的完整数据。IgA肾病是一种进行性慢性自身免疫性疾病。这种在肾脏中的沉积可导致进行性肾脏损伤，并可能导致终末期肾病。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/NjM0MjIyYjU0Mjc1NmY0ZmZkYzFjMzM4MDk2MjY3MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NjM0MjIyYjU0Mjc1NmY0ZmZkYzFjMzM4MDk2MjY3MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1958203","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1583","01952"],"gpt_icon":0},{"id":"2533761533","title":"【券商聚焦】華泰證券：電力現貨市場催生五大投資機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2533761533","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533761533?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 08:55","pubTimestamp":1746579329,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券表示，4月29日，发改委、能源局发布《关于全面加快电力现货市场建设工作的通知》，要求全面加快电力现货市场建设，2025年底前基本实现电力现货市场全覆盖，全面开展连续结算运行，充分发挥现货市场发现价格、调节供需的关键作用。该行认为电力供需趋于宽松的环境为电力市场化加速创造窗口，看好风电、功率预测、四可等投资方向将受益于电力市场化。1.电力市场中风电电价表现或好于光伏，推动占比变化。2.电力市场化下新能源功率预测重要性提升。3.电力市场化或倒逼分布式光伏“四可”升级加速。4.电力市场化推动虚拟电厂商业模式闭环。5.全国统一电力大市场下主网互联互通持续建设。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1958200","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","BK1564","02208","BK1521","LU0254981946.USD","IE0008368742.USD","02688","BK0183","06886","00902","LU1224709979.USD","00836","BK1524","LU1934453819.USD","BK1526","01071","LU1064130708.USD","BK1125","LU0823040885.USD","LU0214875030.USD","BK0028","06865","BK1205","00991","BK1154","BK0188","LU2148510915.USD","02380","01798","BK1583","LU0449515922.USD","LU0737861699.HKD","SG9999014674.SGD","LU2048586759.USD","BK1566","BK1148","LU1064131003.USD","BK1169","601688","01811","BK1546","LU0054450605.USD","03868","00916","BK0276","LU0449509016.USD","LU0821914370.USD","BK1221","01799","LU1515016050.SGD"],"gpt_icon":0},{"id":"2533064309","title":"【晨觀方正】君實生物 / 易普力 / 軍工24年報/25一季報分析 20250507","url":"https://stock-news.laohu8.com/highlight/detail?id=2533064309","media":"方正证券研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533064309?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 08:31","pubTimestamp":1746577867,"startTime":"0","endTime":"0","summary":"“晨观方正”将为大家带来：行业时事君实生物-U：2025Q1业绩亮眼：核心产品特瑞普利销售强劲，在研管线临床进展加速推进易普力：收入稳增，费用节降，订单复苏，并购延伸军工24年报/25一季报分析：存货及合同负债高增彰显行业发展潜力行业时事医药 | 周超泽君实生物-U：2025Q1业绩亮眼：核心产品特瑞普利销售强劲，在研管线临床进展加速推进事件：公司发布2025Q1业绩，总营收5.01亿元，同比增长31.46%，归母净利润-2.35亿元，同比减亏17.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507110604a6d5c778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507110604a6d5c778&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1583","01877","BK1161"],"gpt_icon":0},{"id":"2533643047","title":"雲頂新耀“布地奈德腸溶膠囊”在國內獲完全批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2533643047","media":"医药魔方Info","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533643047?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 08:29","pubTimestamp":1746577777,"startTime":"0","endTime":"0","summary":"5月7日，云顶新耀宣布其布地奈德肠溶胶囊正式获得国家药品监督管理局同意，由附条件批准转为完全批准，取消了对蛋白尿水平的限制，用于治疗具有疾病进展风险的原发性免疫球蛋白A肾病成人患者，以减少肾功能损失。此次完全批准，意味着耐赋康成为国内首个且唯一获得NMPA完全批准的IgA肾病对因治疗药物。耐赋康是口服靶向布地奈德迟释胶囊，是靶向肠道的黏膜免疫调节剂。该协议于2022年3月扩展，将韩国纳入云顶新耀的授权许可范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507110749a474c69b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507110749a474c69b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01952","BK1583"],"gpt_icon":0},{"id":"2533354690","title":"【灣區早參】香港金管局調查：75%中小企指上季銀行貸款批核取態無分別或較容易","url":"https://stock-news.laohu8.com/highlight/detail?id=2533354690","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533354690?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 08:29","pubTimestamp":1746577752,"startTime":"0","endTime":"0","summary":"25%认为银行的有关取态“较困难”，低于前一季的30%。3%受访者表示曾于第一季向银行申请新贷款。其中，5月2日的入住率最高，达98.1%。民航客运量累计达133.61万人次，同比增长24.51%。生效后，Vesync将向联交所申请撤销股份的上市地位。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1958193","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03913","BK1154","BK1147","BK1240","BK1202","06098","BK1144","BK1214","03958","BK1558","159982","01128","BK1610","BK1258","BK1555","BK1172","BK1589","02148","399300","BK1583","BK1564","03931","BK1507","BK1557","BK1594","BK1554","BK1542","BK1229","01033","BK1521","02007","00182","BK1562"],"gpt_icon":0},{"id":"2533448694","title":"Bitwise已向美國SEC提交現貨NEAR ETF的上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2533448694","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533448694?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 07:43","pubTimestamp":1746574985,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cointelegraph.com/news/bitwise-files-s-1-near-etf-sec-approval-s1-filing","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK1583","BK4585","BK4539","BK4588","LU1861558580.USD","BK4112","COIN","BK4516","09983","BK4554","BK1258","BK4535","BK4595","BK1229","BK4550","BK4600","NEAR","BK4551","BK1542","LU1861559042.SGD","BK4596","FDN"],"gpt_icon":0},{"id":"2533692980","title":"萬泰生物艾滋自檢試劑通過世衞組織PQ認證；歸創通橋5月9日起摘“B”丨醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2533692980","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533692980?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 07:41","pubTimestamp":1746574879,"startTime":"0","endTime":"0","summary":"丨2025年5月7日星期三丨NO.1万泰生物：艾滋抗体尿液自检试剂通过世卫组织的PQ认证5月6日，万泰生物公告称，公司收到世界卫生组织（WHO）出具的体外诊断预认证（PQ）确认函，公司的HIV尿液自检试剂-人类免疫缺陷病毒1型尿液抗体检测试剂盒（胶体金法）已通过WHO的预认证，被WHO列入体外诊断产品预认证清单。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202505073397377579.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505073397377579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02190","BK1574","BK1200","LU1981816686.USD","BK1100","BK1587","BK1515","09633","BK1583","BK1589","09939","BK1161"],"gpt_icon":0},{"id":"2533694521","title":"【雲頂新耀(01952.HK)：耐賦康®獲得中國國家藥品監督管理局完全批准用於治療具有疾病進展風險的原發性IgA腎病成人患者】雲頂新耀(01952.HK)發佈公告，耐賦康®(NEFECON®)已獲中國國家藥品監督管理局的完全批准，取消了對蛋白尿水平的限制，用於治療具有疾病進展風險的原發性IgA腎病成人患者。此次完全批准意味着耐賦康®成為中國首個且唯一獲得中國藥監局完全批准的IgA腎病對因治療藥物。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533694521","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533694521?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 07:15","pubTimestamp":1746573349,"startTime":"0","endTime":"0","summary":"云顶新耀(01952.HK)发布公告，耐赋康®(NEFECON®)已获中国国家药品监督管理局的完全批准，取消了对蛋白尿水平的限制，用于治疗具有疾病进展风险的原发性IgA肾病成人患者。此次完全批准意味着耐赋康®成为中国首个且唯一获得中国药监局完全批准的IgA肾病对因治疗药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/07071550177576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1161","BK1574","01952"],"gpt_icon":0},{"id":"2533569450","title":"雲頂新耀(01952)：耐賦康獲得中國國家藥品監督管理局完全批准用於治療具有疾病進展風險的原發性IgA腎病成人患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2533569450","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533569450?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 07:12","pubTimestamp":1746573120,"startTime":"0","endTime":"0","summary":"云顶新耀发布公告，耐赋康已获中国国家药品监督管理局的完全批准，取消了对蛋白尿水平的限制，用于治疗具有疾病进展风险的原发性IgA肾病成人患者。此次完全批准意味着耐赋康成为中国首个且唯一获得中国药监局完全批准的IgA肾病对因治疗药物。这项研究为期2年，包括9个月的耐赋康或安慰剂治疗期，随后是15个月的停药随访期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-07/doc-inevssqn1568968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01952","BK1574","BK1161","BK1583"],"gpt_icon":0},{"id":"2533153699","title":"Bitwise 提交現貨 NEAR ETF 的 S-1 申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2533153699","media":"BitPush","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533153699?lang=zh_tw&edition=fundamental","pubTime":"2025-05-07 06:17","pubTimestamp":1746569843,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bitpush.news//articles/7432848","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bit_push_live","symbols":["BK1258","NEAR","BK1583","BK1229","09983","BK1542"],"gpt_icon":0},{"id":"2533669895","title":"建業新生活“迎舊人” 王俊時隔三年重回CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2533669895","media":"观点网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533669895?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 23:48","pubTimestamp":1746546480,"startTime":"0","endTime":"0","summary":"上一轮大换防中，王俊离开了建业新生活；三年后王俊重回旧地。自2018年6月加入建业集团开始，王俊便担任起建业新生活的董事。不过，建业新生活依旧受困于盈利水平下降难题。尽管建业新生活已实现扭亏为盈，营收重回增长，王俊此时接手的经营压力相对小于前两任CEO，但盈利水平提升并非易事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050702550094ee450b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050702550094ee450b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1542","BK1229","BK1258","09983","BK1583"],"gpt_icon":0},{"id":"2533658966","title":"歸創通橋成為港股首家成功“摘B”的18A高值耗材醫療器械公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2533658966","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533658966?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 22:21","pubTimestamp":1746541260,"startTime":"0","endTime":"0","summary":"5月6日，归创通桥医疗科技股份有限公司（归创通桥，2190.HK）宣布，公司已获得香港联交所批准，将于5月9日起正式将“B”标记从股份代码中移除，这也是港股首家成功“摘B”的18A高值耗材医疗器械公司。归创通桥称，“摘B”不仅标志着公司在市值和收入等方面达到了更高标准，是公司发展历程中的又一里程碑，也意味着公司持续增长及规模化盈利的能力获得资本市场认可，有利于进一步提升资本市场影响力。（澎湃新新闻记者 李潇潇）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506222205a6d523f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506222205a6d523f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09997","HSTECH","09996","BK1587","HSCEI","02190","BK1100","BK1222","BK1574","BK1583"],"gpt_icon":0},{"id":"2533637318","title":"灰度：Diana Zhang 將擔任首席運營官","url":"https://stock-news.laohu8.com/highlight/detail?id=2533637318","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533637318?lang=zh_tw&edition=fundamental","pubTime":"2025-05-06 22:07","pubTimestamp":1746540455,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/Grayscale/status/1919754100360806908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK1542","BK1258","BK1229","ETH","09983","BK1583","BK4601"],"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":6,"totalSize":795,"code":"91000000","status":"200"}]}}